ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI.

May 19, 2006

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

NABCO to close June 30.

January 30, 2004

Oklahoma Cancer Center Recruits Four Professors.

June 15, 2001

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981